Monday 14 October 2013

MALARIA: Weekly Update from Malaria Nexus October 10 2013

 
New encouraging data from ongoing Phase III trial on the malaria vaccine candidate RTS,S
Posted on 10 October 2013
New encouraging data from ongoing Phase III trial on the malaria vaccine candidate RTS,S
GlaxoSmithKline presented this week at the 6th Multilateral Initiative on Malaria PAN African Conference in Durban promising data from an ongoing Phase III trial on the malaria vaccine candidate RTS,S.
 
Dr Jeffrey Dvorin receives a prestigious NIH Director's New Innovator Award
Posted on 10 October 2013
Dr Jeffrey Dvorin receives a prestigious NIH Director's New Innovator Award
Dr Jeffrey Dvorin recently received a prestigious NIH Director's New Innovator Award for his project that aims at generating a list of essential genes in Plasmodium falciparum.
 
Feature Articles
 
Posted on 09 October 2013
1912–2012: a century of research on Plasmodium vivax in vitro culture
Trends in Parasitology, Volume 29, Issue 6, June 2013, Pages 286-294
Florian Noulin, Céline Borlon, Jan Van Den Abbeele, Umberto D’Alessandro, Annette Erhart
 
Posted on 09 October 2013
Distribution of dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles in Plasmodium vivax isolates from Thailand
Acta Tropica, Volume 128, Issue 1, October 2013, Pages 137-143
Pimwan Thongdee, Jiraporn Kuesap, Kanchana Rungsihirunrat, Pongsri Tippawangkosol, Mathirut Mungthin, Kesara Na-Bangchang
 
Posted on 09 October 2013
Evaluation of substituted phenalenone analogues as antiplasmodial agents
Experimental Parasitology, Volume 135, Issue 2, October 2013, Pages 456-458
David Gutiérrez, Ninoska Flores, Teresa Abad-Grillo, Grant McNaughton-Smith
 
Posted on 09 October 2013
Dematin, a human erythrocyte cytoskeletal protein, is a substrate for a recombinant FIKK kinase from Plasmodium falciparum
Molecular and Biochemical Parasitology, Volume 191, Issue 1, September 2013, Pages 20-23
Gabriel S. Brandt, Scott Bailey

 www.malarianexus.com.

No comments:

Post a Comment